<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Lopez Marshall | Activity</title>
	<link>https://www.catswannabecats.com/members/columnvinyl6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/columnvinyl6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lopez Marshall.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c8fb641e98732bce12fdbface2c24969</guid>
				<title>Lopez Marshall posted an update: Onchocerciasis (river blindness) and lymphatic filariasis [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23697/</link>
				<pubDate>Sun, 08 Jun 2025 10:19:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>Onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) are two human neglected tropical diseases that cause major disabilities. Mass administration of drugs targeting the microfilarial stage has reduced transmission and eliminated these diseases in several countries but a macrofilaricidal drug that kills or sterilizes the adult&hellip;<span class="activity-read-more" id="activity-read-more-23697"><a href="https://www.catswannabecats.com/activity/p/23697/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">789a22adc05953f9e900c0a4572e518a</guid>
				<title>Lopez Marshall posted an update: The corresponding intracellular concentrations following the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19775/</link>
				<pubDate>Thu, 05 Jun 2025 09:43:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>The corresponding intracellular concentrations following the treatment at 5 μM were 0.05 ± 0.01, 0.24 ± 0.04, and 0.25 ± 0.02 mM (n ≥ 189). FADDI-096 was mainly localized throughout the cytoplasm and nuclear region over 24 h. The intracellular zinc concentration increased in a concentration- and time-dependent manner. This is the first study to qu&hellip;<span class="activity-read-more" id="activity-read-more-19775"><a href="https://www.catswannabecats.com/activity/p/19775/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">67fe678c7319672ffdf376aec04a6751</guid>
				<title>Lopez Marshall posted an update: Residual inflammatory risk (RIR) after acute coronary [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/6664/</link>
				<pubDate>Sat, 31 May 2025 16:58:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>Residual inflammatory risk (RIR) after acute coronary syndromes (ACS) may identify patients likely to benefit from anti-inflammatory therapies.</p>
<p> Patients from the Special Program University Medicine ACS cohort were divided into four groups according to level of hsCRP at baseline and after 12 months persistently high RIR, increased RIR&hellip;<span class="activity-read-more" id="activity-read-more-6664"><a href="https://www.catswannabecats.com/activity/p/6664/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">348ab4724a0cdf1aa4868f4292123090</guid>
				<title>Lopez Marshall became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5843/</link>
				<pubDate>Sat, 31 May 2025 15:23:16 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>